VUZIX CORP (VUZI)

US92921W3007 - Common Stock

1.42  -0.08 (-5.33%)

After market: 1.4682 +0.05 (+3.39%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to VUZI. VUZI was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. VUZI has a great financial health rating, but its profitability evaluates not so good. VUZI is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

VUZI had negative earnings in the past year.
In the past year VUZI has reported a negative cash flow from operations.
In the past 5 years VUZI always reported negative net income.
VUZI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

VUZI has a Return On Assets of -64.88%. This is amonst the worse of the industry: VUZI underperforms 89.60% of its industry peers.
With a Return On Equity value of -68.29%, VUZI is not doing good in the industry: 82.40% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -64.88%
ROE -68.29%
ROIC N/A
ROA(3y)-38.74%
ROA(5y)-50.87%
ROE(3y)-41.7%
ROE(5y)-56.78%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VUZI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

VUZI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VUZI has more shares outstanding
Compared to 5 years ago, VUZI has more shares outstanding
There is no outstanding debt for VUZI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 7.29 indicates that VUZI is not in any danger for bankruptcy at the moment.
VUZI's Altman-Z score of 7.29 is amongst the best of the industry. VUZI outperforms 84.80% of its industry peers.
VUZI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.29
ROIC/WACCN/A
WACC9.36%

2.3 Liquidity

VUZI has a Current Ratio of 9.41. This indicates that VUZI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 9.41, VUZI belongs to the best of the industry, outperforming 91.20% of the companies in the same industry.
VUZI has a Quick Ratio of 6.57. This indicates that VUZI is financially healthy and has no problem in meeting its short term obligations.
VUZI has a Quick ratio of 6.57. This is amongst the best in the industry. VUZI outperforms 87.20% of its industry peers.
Industry RankSector Rank
Current Ratio 9.41
Quick Ratio 6.57

1

3. Growth

3.1 Past

VUZI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.19%.
VUZI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.53%.
VUZI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.44% yearly.
EPS 1Y (TTM)-17.19%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q0%
Revenue 1Y (TTM)-26.53%
Revenue growth 3Y1.56%
Revenue growth 5Y8.44%
Revenue growth Q2Q-52.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y29.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.83%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

VUZI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VUZI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

VUZI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VUZIX CORP

NASDAQ:VUZI (5/17/2024, 7:00:02 PM)

After market: 1.4682 +0.05 (+3.39%)

1.42

-0.08 (-5.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap91.92M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.88%
ROE -68.29%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 9.41
Quick Ratio 6.57
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-17.19%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y29.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-26.53%
Revenue growth 3Y1.56%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y